Search Results 7551-7560 of 26308 for oral

  1. Publications - Ana I. Casanegra, M.D., M.S. - Mayo Clinic

    Evaluation of extended direct oral anticoagulant dosing strategies in patients with and without cancer from a prospective observational registry. Res Pract ...

  2. A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury - Mayo Clinic

    The MID/OCT group received midodrine orally at an initial dose of 7.5 mg thrice daily, with the dose increased to a maximum of 12.5 mg thrice daily ...

  3. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

    Able to swallow oral medication. Both female and male patients of reproductive potential must agree to avoid pregnancy or impregnating a partner ...

  4. Research led by Mayo Clinic Establishes Mortality Risk for Refractory Celiac Disease Patients

    Common Oral Problems: Mayo Clinic Radio Health Minute. Related Articles. (VIDEO) Leaving Mayo Clinic with answers, a plan of care, hope featured. Featured News.

  5. African American Professional Women Positive on Medical Research - Mayo Clinic News Network

    “The more African Americans, both women and men, who participate in medical research, the better informed their physicians will be in treating a wide range of ...

  6. Spinal cord tumor - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  7. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

    Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

  8. A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/​A011-16) - Mayo Clinic

    The use of an oral phosphodiesterase type 5 inhibitor, if only indicated for erectile dysfunction, is permitted, if not administered within 48 hours of a ...

  9. Spinal cord tumor - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  10. Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Metastatic Endometrial Cancer - Mayo Clinic

    ... oral anticoagulants; low-dose aspirin (=< 81 mg/day), low-dose warfarin (=< 1 mg/day), and prophylactic low molecular weight heparin (LMWH) are permitted.